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Background: There is an overall paucity of data regarding the outcomes of patients with acetaminophen-associated
toxic hepatitis in Taiwan. Therefore, the purpose of this study was to recruit a larger number of patients and to
examine the clinical features, the degrees of toxic hepatitis, the physiological markers, and the clinical outcomes after
intentional acetaminophen poisoning, and to determine what association, if any, might exist between these findings.
Methods: We examined the medical records of 187 patients with intentional acetaminophen poisoning who were
examined at Chang Gung Memorial Hospital between 2000 and 2011. Patients were categorized into 2 groups
according to hepatic complications, i.e. with (n = 15) or without (n = 172) toxic hepatitis. Demographic, clinical, and
laboratory data were collected, and the mortality rate was analyzed.
Results: It was found that patients with toxic hepatitis had higher serum acetaminophen level (P = 0.007), but they
also arrived to the hospital later (P < 0.001) than patients without toxic hepatitis. Furthermore, patients with toxic
hepatitis showed higher incidences of acute respiratory failure (P = 0.012) than those shown by patients who did not
have hepatitis. The laboratory examinations also revealed greater degrees of granulocytosis (P < 0.001) and poorer liver
function tests (P < 0.001) in patients with hepatitis than in patients without hepatitis. Nevertheless, a univariate logistic
regression model failed to identify any significant risk factors for toxic hepatitis complication after ingestion (P > 0.05).
At the end of the analysis, 1 patient with toxic hepatitis died of liver failure. Finally, there was no significant difference
in mortality between patients with and without hepatitis (P = 0.080).
Conclusion: The analytical data revealed that toxic hepatitis was not uncommon (15/187 or 8.0%) after acetaminophen
overdose. Further studies are warranted.
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Acetaminophen is one of the best-selling analgesics in
Taiwan and one of the most popular drugs in the world.
Although it is safe at therapeutic doses, overdoses of
acetaminophen can cause severe liver injury. Although
the first case of acetaminophen-related hepatic necrosis
due to overdose was documented in 1966 (Davidson and* Correspondence: m19570@adm.cgmh.org.tw
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in any medium, provided the original work is pEastham, 1966), it is still the leading agent of liver failure
due to poisoning (Lee, 2004).
Acetaminophen is ingested orally. The daily maximum
dose is 4 g for an adult and 80 mg/kg for a child. After
ingestion, the concentration peaks around 2 h. Dosages
that induce toxic hepatitis are greater than 12 g per day
in adults and 250 mg/kg over 24 h in children (Makin et al.,
1995). After ingestion, around 90% of the acetaminophen
is metabolized to sulfate and glucuronide, which is conju-
gated in the liver and then excreted into the urine. Eight
percent of the remaining acetaminophen is metabolized by
cytochrome p450 into the more toxic form of N-acetyl-p-
benzoquinoneimine (NAPQI) when the glutathione (GSH)open access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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binds to the cysteine group in the hepatocyte, and oxida-
tive injury and hepatocellular centrilobular necrosis is then
induced (Jollow et al., 1973). However, N-acetylcysteine
limits the toxicity of acetaminophen by increasing the GSH
stores, binding with NAPQI as a substitute for GSH, and
enhancing sulfate conjugation (Lee, 2004).
There is an overall paucity of data regarding the out-
comes of patients with acetaminophen poisoning in
Taiwan. In the only original research study, Tsai et al.
(Tsai et al., 2004) have reported that age and the time to
presentation were the independent risk factors for
hepatotoxicity (P = 0.033 and P = 0.002, respectively)
after acetaminophen intoxication. However, due to their
low sample size, the certainty of the conclusions may be
limited.
Therefore, the purpose of this study was to recruit a
larger number of patients and to examine the clinical
features, the degrees of toxic hepatitis, the physiological
markers, and the clinical outcomes after intentional
acetaminophen poisoning, and to determine what associ-
ation, if any, might exist between these findings.
Materials and methods
Ethics statement
This retrospective observational study complied with the
guidelines of the Declaration of Helsinki and was
approved by the Medical Ethics Committee of Chang
Gung Memorial Hospital, which is a tertiary referral
center located in the northern part of Taiwan. Because
this study involved a retrospective review of existing
data, the Institutional Review Board approval was ob-
tained, but specific informed consents were not obtained
from the patients. However, informed consents of the
risks of acute acetaminophen poisoning and all treat-
ment modalities were obtained from all patients upon
their initial admission. In addition, all individual infor-
mation was securely protected by delinking identifying
information from the main data set and available to
investigators only. Furthermore, all of the data were
analyzed anonymously. The Institutional Review Board
of Chang Gung Memorial Hospital specifically waived
the need for consent. Finally, all primary data were
collected according to the Strengthening the Reporting
of Observational Studies in Epidemiology guideline. The
policy was based on previous publication (Liu et al., 2012;
Chen et al., 2013, Yu et al., 2013).
Patients
We examined the records of 187 patients with intentional
acetaminophen poisoning who were examined at Chang
Gung Memorial Hospital between 2000 and 2011.
Demographic, clinical, and laboratory data were collected,
and the mortality rate was analyzed. The diagnoses ofacetaminophen intoxication were based on clinical,
physical and laboratory examinations, and confirmed by
plasma acetaminophen levels (fluorescence polarization
immunoassay).
Inclusion and exclusion criteria
All patients who were older than 18 years of age and
who were diagnosed with acetaminophen poisoning at
Chang Gung Memorial Hospital between 2000 and 2011
were eligible for inclusion in this study. Patients were
excluded if they were younger than 18 years or did not
have detectable acetaminophen levels in the blood
despite a positive history of ingestion or if they had
major systemic comorbidities, such as cancer or heart,
lung, renal, or liver diseases.
Detoxification protocol
The protocols that were used to treat patients included
gastric lavage with large amounts of normal saline,
which was followed by the infusion of 1 g/kg activated
charcoal and 250 mL magnesium citrate through a naso-
gastric tube. Magnesium citrate was used to prevent
constipation after the charcoal administration. The use
of the N-acetylcysteine antidote was determined with
toxicity estimations from the Rumack-Matthew nomo-
gram for single acute acetaminophen overdose/ingestion
(Wolf et al., 2007).
Definitions of clinical events
Acetaminophen related toxic hepatitis was diagnosed if
the alanine aminotransferase (ALT) increase was more
than 1000 U/L (McClain et al., 1999; Vale and Proudfoot,
1995; Ayonrinde et al., 2005). Hepatitis B virus carrier was
defined as positive hepatitis B surface antigen in the blood
of more than 6 months. Acute renal failure was defined as
serum creatinine levels over 1.3 mg/dL (Weng et al.,
2012). Acute respiratory failure has been defined as a
condition of respiratory insufficiency requiring intubation
and mechanical ventilation for more than 24 h, regardless
of the fraction of inspired oxygen (Luhr et al., 1999).
Statistical analysis
The continuous variables are expressed as means and
standard deviations, and categorical variables are
expressed as numbers with percentages in brackets. All
data were tested for the normality of distribution and
the equality of standard deviations before the analysis.
For comparisons between patient groups, we used
Student’s t-tests for the quantitative variables and Chi-
square or Fisher’s exact tests for the categorical variables.
An initial univariate Cox regression analysis was per-
formed in order to compare the frequencies of the pos-
sible risk factors that were associated with toxic hepatitis
complication. In order to control for possible confounding
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backward approach) was performed in order to analyze
those factors that were significant in the univariate models
(P < 0.05) and that met the assumptions of a proportional
hazard model. We considered the results that rejected the
null hypothesis with 95% confidence to be significant. All
analyses were performed with the IBM SPSS Statistics
Version 20 software program (IBM Corporation, Armonk,
NY, USA).
Results
Table 1 outlines the baseline characteristics of the 187
patients with acetaminophen poisoning who were
grouped according to hepatitis complications. It was
found that patients with toxic hepatitis had higher serum
acetaminophen level (P = 0.007) and they also arrived to
the hospital later (P < 0.001) than patients without toxic
hepatitis. Notably, the prevalence of hepatitis B virus
carrier was also higher in patients with than patients
without toxic hepatitis (P < 0.001).
As shown in Table 2, patients with toxic hepatitis
showed higher incidences of acute respiratory failure
(P = 0.012) than those shown by the patients who did
not have hepatitis. The laboratory examinations revealed
greater degrees of granulocytosis (P < 0.001) and poorer
liver function tests (P < 0.001) in patients with hepatitis
than in patients without hepatitis (Table 3).
Table 4 shows that most patients were treated aggres-
sively with gastric lavage, which was followed by an
infusion of activated charcoal and magnesium citrate.Table 1 Baseline characteristics of patients with acetaminoph
Variable Total (N = 187)
Serum acetaminophen (μg/mL) 57.6 ± 60.3
Acetaminophen amount (tablet, 500 mg per tablet) 37.1 ± 25.2
Age (years) 28.9 ± 12.1
Male, n (%) 35 (18.7)
Time elapsed between acetaminophen ingestion and
hospital arrival (hour)
6.2 ± 6.0
Hepatitis B virus carrier, n (%) 10 (5.3)
Alcohol consumption, n (%) 35 (18.7)
Smoking habit, n (%) 29 (15.5)
Hypertension, n (%) 6 (3.3)
Diabetes mellitus, n (%) 3 (1.6)
Malignancy, n (%) 3 (1.6)
Depressive disorder, n (%) 125 (66.8)
Amphetamine abuse, n (%) 1 (0.5)
Ketamine abuse, n (%) 2 (1.1)
Heroin abuse, n (%) 0 (0)
Use of benzodiazepine hypnotics, n (%) 40 (21.4)
Note: **P < 0.01, ***P < 0.001.In addition, most patients were treated with the N-
acetylcysteine antidote. Nevertheless, patients with
toxic hepatitis received lesser proportion of gastric
lavage and active charcoal than patients without toxic
hepatitis (P = 0.002).
At the end of the analysis, 1 patient with toxic
hepatitis died of liver failure (Table 4). Nevertheless,
there was no significant difference in mortality between
patients with and without hepatitis (P = 0.051).
Finally, a univariate logistic regression analysis failed
to identify any significant risk factors for toxic hepatitis
complication after ingestion (Table 5).
Discussion
Acetaminophen is a well-known agent that causes dose-
dependent toxic hepatitis. It was revealed in this study
that although patients with toxic hepatitis suffered
higher serum acetaminophen levels than patients
without toxic hepatitis, a univariate logistic regression
analysis failed to identify serum acetaminophen level as
a significant risk factor for toxic hepatitis complication
after ingestion, possibly due to small sample size and
short follow up duration (Table 5). Theoretically, the
toxic metabolite NAPQI is formed by cytochrome p450
and then detoxified by conjugating with GSH (Nelson,
1990), and oversaturated NAPQI makes the hepatocytes
more vulnerable to injury (Potter et al., 1973). Neverthe-
less, the amount of acetaminophen in patients without
toxic hepatitis in was 36.5 ± 25.1 tablets (or 17.8 ±
12.6 g), which was much higher than 4 g, the maximumen poisoning (N = 187)
No toxic hepatitis (N = 172) Toxic hepatitis (N = 15) P
114.4 ± 98.6 238.1 ± 300.0 0.007**
36.5 ± 25.1 44.2 ± 27.0 0.973
29.0 ± 12.4 28.4 ± 8.3 0.550
31 (18.0) 4 (26.6) 0.300
5.4 ± 4.1 16.1 ± 13.5 <0.001***
6 (3.5) 4 (26.6) <0.001***
32 (18.6) 3 (20.0) 0.599
26 (15.1) 3 (20.0) 0.420
5 (2.9) 1 (6.7) 0.399
3 (1.7) 0 (0) 0.777
3 (1.7) 0 (0) 0.777
114 (66.2) 11 (73.3) 0.404
1 (0.7) 0 (0) 0.607
1 (0.7) 0 (0) 0.308
0 (0) 0 (0) 1.000
38 (22.1) 2 (13.3) 0.338
Table 2 Clinical manifestations of patients with acetaminophen poisoning (N = 187)
Variable Total (N = 187) No toxic hepatitis (N = 172) Toxic hepatitis (N = 15) P value
Vital signs
Systolic blood pressure (mmHg) 120.8 ± 18.8 120.1 ± 17.8 127.9 ± 26.1 0.008**
Diastolic blood pressure (mmHg) 72.6 ± 13.3 72.3 ± 13.0 75.9 ± 16.0 0.301
Heart rate (beat per minute) 82.1 ± 16.4 81.9 ± 16.1 83.4 ± 20.0 0.494
Body temperature (°C) 36.8 ± 4.4 36.8 ± 4.6 36.9 ± 0.84 0.718
Urinary system
Acute renal failure, n (%) 0 (0) 0 (0) 0 (0) 1.000
Gastrointestinal system
Nausea and vomiting, n (%) 81 (43.3) 71 (41.2) 10 (66.6) 0.052
Neurologic system
Conscious disturbance, n (%) 41 (21.9) 38 (22.0) 3 (20.0) 0.575
Headache, n (%) 8 (4.3) 7 (4.1) 1 (5.1) 0.768
Seizure, n (%) 2 (1.1) 1 (0.01) 1 (5.1) 0.154
Respiratory system
Acute respiratory failure, n (%) 7 (3.7) 4 (2.3) 3 (20.0) 0.012*
Note: *P < 0.05, **P < 0.01.
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injury may be the major determinant for this because
previous animal studies have demonstrated that NADQI
binds to mitochondria and leads to oxidative stress
(Jaeschke, 1990). NADQI induced mitochondria per-
meability transition pore opening and mitochondrial
permeability changes (Bajt et al., 2006). Endonuclease G
and the apoptosis-inducing factor are released by mito-
chondria, and DNA fragmentation occurs with the release
of these enzymes (Kon et al., 2004). Although oversatura-
tion is the major mechanism in acetaminophen-related
toxic hepatitis, mitochondria-related cytotoxic damage
may be the reason for the heterogeneity of the phenotypes
after the ingestion of large amounts of acetaminophen.
In this study, 1 patient with toxic hepatitis died of liver
failure, and the overall mortality rate was 0.5% (Table 4).
Evidently, the favorable outcomes depended on a prompt
diagnosis of acetaminophen poisoning and the immedi-
ate institution of detoxification protocols. In US reports
on acetaminophen-related acute hepatitis and liver fail-
ure, the mortality rate has been reported to be around
19–30% (Lee, 2008; Schiodt et al., 1997). Larson et al.
(Larson et al., 2005) have reported that 27% of US
patients with acetaminophen-induced acute liver failure
died in 3 weeks. Therefore, our mortality rate was much
lower than the data from the US Poison Centers. In
terms of metabolism (Patel et al., 1992), acetaminophen
is extensively conjugated with glucuronic acid and
sulfate prior to renal excretion. A minor metabolic route
involves the microsomal oxidation of acetaminophen
to a hepatotoxic reactive intermediate, which subse-
quently undergoes GSH conjugation, yielding cysteineand mercapturate conjugates, both of which are ex-
creted in the urine. In a previous pharmacogenetic
study (Patel et al., 1992), it has been reported that
the mean fractional excretion of cysteine metabolites
differed between Caucasians and Orientals (P < 0.005).
Therefore, it is unclear whether the low mortality rate
in our study can be explained by ethnic differences
in enzymatic metabolism between Orientals and
Caucasian.
The prevalence of hepatitis B virus carrier in Taiwan is
around 15–20%, which is higher than in the Europe or
US (Ott et al., 2012; Lee et al., 2013). The percentage of
the hepatitis B virus carrier in our study was 5.3%
(Table 1), which was much lower than national Taiwanese
registry (Lee et al., 2013). Nevertheless, the prevalence of
hepatitis B virus carrier was higher in patients with than
patients without toxic hepatitis (Table 1). Although the
presence of hepatitis B carrier was not longer a significant
predictor for toxic hepatitis after logistic regression
analysis (Table 5), it was the authors’ thought that the viral
carrier status might make hepatocytes more vulnerable to
toxic injury. Literature data on the influence of acetami-
nophen intake on acute viral hepatitis is scarce. It was dis-
closed in a small clinical study (Yaghi et al., 2006) that the
use of acetaminophen at therapeutic doses was associated
with greater alterations of surrogate markers of the sever-
ity of acute viral hepatitis. On the other hand, susceptibil-
ity to acetaminophen toxicity was unexpectedly decreased
during acute viral hepatitis in mice (Getachew et al.,
2010). Therefore, further studies should be considered to
confirm if infected hepatocytes are more vulnerable to
acetaminophen toxicity.
Table 3 Laboratory data of patients with acetaminophen poisoning (N = 187)
Variable Total (N = 187) No toxic hepatitis (N = 172) Toxic hepatitis (N = 15) P value
First day (arrival)
Hemoglobin (g/dL) 13.4 ± 1.5 13.4 ± 1.5 13.6 ± 1.3 0.589
Neutrophils (/μL) 9078.7 ± 4077.6 8747.5 ± 3271.6 10305.4 ± 6123.8 <0.001***
Platelet (103/μL) 246.3 ± 68.9 250.9 ± 61.9 196.5 ± 111.7 0.006
Urea nitrogen (mg/dL) 8.8 ± 4.5 8.9 ± 4.6 7.6 ± 3.4 0.542
Creatinine (mg/dL) 0.8 ± 0.2 0.7 ± 0.2 0.8 ± 0.3 0.060
Sodium 140.1 ± 3.2 140.2 ± 3.2 139.1 ± 2.5 0.180
Potassium 3.6 ± 1.6 3.6 ± 1.7 3.3 ± 0.4 0.584
AST (U/L) 146.1 ± 1125.7 31.1 ± 34.4 1497.6 ± 3915.7 <0.001***
ALT (U/L) 75.4 ± 380.6 23.6 ± 31.9 720.7 ± 1264.8 <0.001***
Total bilirubin (mg/dL) 1.0 ± 0.5 0.9 ± 0.4 1.7 ± 1.0 <0.001***
Albumin (g/dL) 4.0 ± 0.7 4.1 ± 0.6 3.6 ± 0.7 0.588
Prothrombin time (INR, sec) 1.2 ± 0.4 1.1 ± 0.1 2.0 ± 0.9 0.000***
γ-glutamyl transferase (U/L) 75.6 ± 107.3 39.6 ± 61.5 290.1 ± 16.3 0.327
Alkaline phosphatase (U/L) 51.6 ± 19.2 47.7 ± 16.4 70.1 ± 21.9 0.433
Ammonia 81.0 ± 67.6 54.5 ± 29.6 137.6 ± 92.0 0.010
Second day
AST (U/L) 503.1 ± 2005.0 37.4 ± 75.9 3962.7 ± 4637.8 <0.001***
ALT (U/L) 377.0 ± 1254.8 47.1 ± 117.2 3148.5 ± 2532.4 <0.001***
Total bilirubin (mg/dL) 1.2 ± 1.3 0.9 ± 0.6 2.9 ± 2.4 <0.001***
Prothrombin time (INR, sec) 1.1 ± 0.1 2.4 ± 0.8 <0.001***
Fourth day
AST (U/L) 302.4 ± 931.7 35.5 ± 63.2 1575.4 ± 1791.3 <0.001***
ALT (U/L) 343.0 ± 1035.4 56.4 ± 126.4 2745.4 ± 1915.3 <0.001***
Total bilirubin (mg/dL) 0.9 ± 0.8 0.7 ± 0.5 1.8 ± 1.3 <0.001***
Prothrombin time (INR, sec) 1.1 ± 0.1 1.9 ± 0.8 <0.001***
Note: ***P < 0.001.
Table 5 Clinical predictors of toxic hepatitis after
acetaminophen poisoning (N = 187)
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hepatitis was within hours after acetaminophen exposure
(Table 3), which was in sharp contrast to our previous
experience with paraquat-induced toxic hepatitis (Yang
et al., 2012). In paraquat patients, the symptoms of toxic
hepatitis usually developed within 6.7 ± 6.3 days of
exposure, peaked at 9.5 ± 8.8 days, and were resolved in
17.3 ± 9.8 days. It was hypothesized by Mullick et al.Table 4 Treatment and outcome of patients with










Gastric lavage, n (%) 122 (65.2) 118 (68.6) 4 (26.7) 0.002**
Active charcoal and
magnesium citrate, n (%)
122 (65.2) 118 (68.6) 4 (26.7) 0.002**
N-acetylcysteine, n (%) 147 (78.6) 133 (77.3) 14 (93.3) 0.212
Mortality, n (%) 1 (0.5) 0 (0) 1 (6.7) 0.080
Note: **P < 0.01.(Mullick et al., 1981) that paraquat injury to the liver is
biphasic; it is initially hepatocellular but becomes cho-
langiocellular after the first 2 days. However, only
hepatocellular damage mechanisms have been implicated







(each increase of 1 μg/mL)
1.006 0.997-1.016 0.210
Acetaminophen amount
(each increase of 1 tablet)
1.039 0.984-1.096 0.169
Hepatitis B virus carrier (yes) 0.000 0.000-0.000 0.999
Time elapsed between
acetaminophen
ingestion and hospital arrival
(each increase of 1 hour)
1.260 0.241-9.438 0.660
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hepatitis in cases of acetaminophen poisoning can be
explained by different liver injury mechanisms.
In this study, patients with toxic hepatitis received
lesser proportion of gastric lavage and active charcoal
than patients without toxic hepatitis (Table 4). This
could be due to longer time elapse between acetamino-
phen ingestion and hospital arrival in patients with than
without toxic hepatitis (Table 1). Similarly, the time
elapse was not a significant risk factor for mortality after
logistic regression analysis (Table 5). In a study that was
conducted in Hong Kong (Chan et al., 1996), it was
found that the time that elapsed between acetaminophen
ingestion and treatment was the most important prog-
nostic factor for liver toxicity. However, the N-acetylcysteine
antidote was only used in 50% of the patients (Chan
et al., 1996), but the proportion of patients that
received N-acetylcysteine treatment was as high as
78.6% in our study (Table 4). Therefore, it is unclear
whether the difference in the use of the N-acetylcysteine
antidote could influence predictions of time elapses for
toxic hepatitis.
The analytical results showed that patients with
toxic hepatitis showed higher incidences of acute re-
spiratory failure than those shown by the patients
who did not have hepatitis (Table 2). The results of a
laboratory study (Ilic et al., 2010) have also indicated
that a high hepatotoxic dose of paracetamol (5 g per
kg intraperitoneally) produced hepatic encephalopathy
with generalized convulsions in rats. Hepatic coma by
liver failure may be possible cause inducing respira-
tory failure or high anion gap metabolic acidosis
(Mendoza et al., 2006).
In summary, the analytical data revealed that toxic
hepatitis was not uncommon (15/187 or 8.0%) after acet-
aminophen overdose. Nevertheless, this study failed to
identify any significant risk factors for mortality, possibly
due to low sample size and short follow up duration.
Further studies are warranted.
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